NEW YORK (GenomeWeb News) – Nanogen today said that it will collaborate with Italian firm A. Menarini Diagnostics to sell CE-marked in vitro diagnostic kits based on Nanogen’s MGB technology for infectious diseases.
 
Nanogen will manufacture the kits, which will be branded as Menarini products and sold by the Italian firm in Europe. The San Diego-based firm did not disclose which infectious diseases the molecular diagnostic test kits will target, but it said products would be introduced to the market in 2009.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.